- Home
- IINN vs BRTX Comparison
IINN vs BRTX Comparison
Compare IINN & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IINN
- BRTX
- Stock Information
- Founded
- IINN 2018
- BRTX 1997
- Country
- IINN Israel
- BRTX United States
- Employees
- IINN N/A
- BRTX N/A
- Industry
- IINN Medical/Dental Instruments
- BRTX Managed Health Care
- Sector
- IINN Health Care
- BRTX Health Care
- Exchange
- IINN Nasdaq
- BRTX Nasdaq
- Market Cap
- IINN 13.7M
- BRTX 13.7M
- IPO Year
- IINN 2021
- BRTX N/A
- Fundamental
- Price
- IINN $0.73
- BRTX $1.81
- Analyst Decision
- IINN Strong Buy
- BRTX Strong Buy
- Analyst Count
- IINN 1
- BRTX 1
- Target Price
- IINN $2.00
- BRTX $18.00
- AVG Volume (30 Days)
- IINN 825.5K
- BRTX 27.1K
- Earning Date
- IINN 06-13-2025
- BRTX 05-14-2025
- Dividend Yield
- IINN N/A
- BRTX N/A
- EPS Growth
- IINN N/A
- BRTX N/A
- EPS
- IINN N/A
- BRTX N/A
- Revenue
- IINN N/A
- BRTX $391,000.00
- Revenue This Year
- IINN N/A
- BRTX $391.52
- Revenue Next Year
- IINN N/A
- BRTX $3.50
- P/E Ratio
- IINN N/A
- BRTX N/A
- Revenue Growth
- IINN N/A
- BRTX 161.54
- 52 Week Low
- IINN $0.40
- BRTX $1.03
- 52 Week High
- IINN $2.17
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- IINN 66.69
- BRTX 56.98
- Support Level
- IINN $0.53
- BRTX $1.68
- Resistance Level
- IINN $0.80
- BRTX $1.79
- Average True Range (ATR)
- IINN 0.08
- BRTX 0.06
- MACD
- IINN 0.03
- BRTX 0.02
- Stochastic Oscillator
- IINN 81.36
- BRTX 94.83
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.